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Chemokine-Mediated Migration of Skin-Derived Stem
Cells: Predominant Role for CCL5/RANTES
Kim L. Kroeze1, Wouter J. Jurgens2, Behrouz Z. Doulabi3, Florine J. van Milligen4, Rik J. Scheper4 and
Susan Gibbs1
The ability of stem cells to self-renew as well as their multilineage differentiation potential makes them
ideal candidates for skin regeneration strategies. Mesenchymal stem cells residing in human adult dermis, in
contrast to adipose tissue, have not yet been described. The objective of this study was to determine the
stemness and chemokine-mediated homing potential of dermal stromal cells (DSC) and to compare this with
adipose stem cells (ASC). DSC have a less stellate form than ASC, confirming that DSC and ASC are two different
types of mesenchymal cell populations. However, DSC display a mesenchymal stem cell phenotype
(CD31, CD34þ , CD45, CD54þ , CD90þ , CD105þ , and CD166þ ) similar to ASC and are also multipotent in
their ability to differentiate into adipocytes, chondrocytes, and osteoblasts. Both ASC and DSC display a similar
set of chemokine receptors (CCR3, CCR4, CCR6, CCR10, CXCR1, and CXCR2). Several ligands for these
receptors, with CCL5/RANTES being the most potent, can induce migration of ASC and DSC in an in vitro
wound-healing assay. Taken together, these results show that a population of mesenchymal stem cells resides in
the dermis of human adult skin and these dermal-derived stem cells have a phenotypic and chemokine-
mediated homing potential similar to adipose stem cells, which to our knowledge is previously unreported.
Journal of Investigative Dermatology (2009) 129, 1569–1581; doi:10.1038/jid.2008.405; published online 1 January 2009
INTRODUCTION
Recently, increasing focus is being placed on the use of stem
cell (SC) applications for the treatment of difficult to heal
cutaneous wounds, such as deep burns and trauma-
induced wounds (Falanga et al., 2007; Prichard et al.,
2007). Currently these wounds heal slowly and result in
excessive scar formation. SCs represent a population of
multipotent cells capable of differentiating into a number of
mesodermal lineages when triggered by the appropriate
microenvironment. SCs were first isolated from bone marrow,
but have also been reported to be present in other tissues
such as adipose tissue, postnatal dermis, umbilical cord
blood, peripheral blood, skeletal muscle, and brain
(Bartsch et al., 2005; Chamberlain et al., 2007; Oedayr-
ajsingh-Varma et al., 2007). The ability of SCs to self-renew
as well as their transdifferentiation potential makes them
ideal candidates for skin regeneration strategies.
During normal cutaneous wound-healing, growth and
directed migration of skin residential and regenerative SCs
into the affected area is thought to be essential for
reepithelialization, fibroblast repopulation of the dermal
matrix, and angiogenesis. These processes are most probably
regulated by chemokine (CK) and chemokine receptor (CKR)
interactions. This is supported by the differential and
sequential expression of CKs during skin injury (Gillitzer
and Goebeler, 2001) and several other findings: CXCL8 and
CXCL1 enhance keratinocyte growth (Steude et al., 2002);
CXCR2/ mice show delayed reepithelialization and
decreased vasculogenesis (Devalaraja et al., 2000) and
CXCR3/ mice show a delayed dermal maturation (Yates
et al., 2007).
Homing of bone marrow-derived SCs into the epidermis of
mice skin, followed by transdifferentiation into keratinocytes
has very recently been demonstrated by Inokuma et al.
(2006). These results support the hypothesis that SCs, once in
an appropriate microenvironment, will differentiate and in
doing so repair the damaged tissue. This homing into the
epidermis was shown to be regulated by specific CK/CKR
interactions, in particular CCL27/CCR10 (Inokuma et al.,
2006). Several groups have recently been studying the
expression of the CKR profile on human mesenchymal SCs
derived from the bone marrow (Honczarenko et al., 2006;
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Ponte et al., 2007; Ringe et al., 2007). The CKR profile of
mesenchymal SCs derived from other human tissues has not
yet been reported.
In deep skin wounds, the underlying adipose tissue is
exposed in the wound bed and the dermis at the wound
margins. Optimal tissue regeneration strategies aimed at
scar-free healing in the future might be able to target
SCs residing in the adipose tissue and dermis. A number
of reports describe the presence of SCs within the adipose
tissue of human adult skin. These cells exhibit a
CD31CD34þCD45CD54þCD90þCD105þCD166þ me-
senchymal SC phenotype and have been shown to be
multipotent by their ability to differentiate into chondrocytes
and osteoblasts (Zuk et al., 2002; Ponte et al., 2007;
Oedayrajsingh-Varma et al., 2007). With regard to dermal
tissue only a single report describes the presence of multi-
potent SCs in human postnatal foreskin (Prichard et al.,
2007). It is unknown whether adult human dermis also
contains mesenchymal SCs. Optimal skin regeneration
strategies also depend on the homing capacities of SCs to
the site of injury. The CKR CXCR4, which is reported to be
present in adipose stem cells (ASCs; Cho et al., 2006;
Chamberlain et al., 2007), may play a role in this homing, but
no comprehensive study on ASC CKR profiles has been
reported. Also, no information is available on CKR expression
on dermis-derived stromal cells.
The aim of the present study was to determine whether
or not mesenchymal SCs are present in adult human
dermis and to determine the CK-mediated homing
potential of these cells compared to adipose-derived SCs.
Therefore, dermis-derived stromal cells (DSC) and ASC were
isolated from human adult abdominal skin. Both cell
populations were first compared with regard to phenotypic
parameters such as SC marker expression profile and their
multilineage differentiation potential. Next, the CKR profile
was studied using flow cytometry. Whether receptor expres-
sion facilitated cell migration was determined in an in vivo
scratch assay, a well-established wound-healing model
(Entschladen et al., 2005). Knowledge on the presence of
SCs in the skin and the effect of CKs on migration of these
cells is of importance for future CK-based therapies. These
therapies are aimed at homing SCs into difficult to heal
wounds to achieve optimal tissue regeneration.
RESULTS
Phenotypic characterization of ASC and DSC
Adipose tissue of human adult skin contains a stromal
vascular fraction (SVF) with a rich source of SCs, but also
adipocytes, endothelial cells and infiltrating cells. In this
manuscript the uncultured cell population isolated from
adipose tissue is referred to as the adipose stromal vascular
fraction (ASVF) and the cultured cells at passage 3 are
referred to as ASC. The mesenchymal cell population isolated
and cultured from the dermis of human adult skin is studied
for its SC characteristics. In this manuscript the uncultured
cell population isolated from human adult dermis is referred
to as the dermal stromal vascular fraction (DSVF), containing
predominantly fibroblasts and endothelial cells, but also
infiltrating cells such as macrophages. The cultured cells at
passage 3 are referred to as DSC.
Both ASC and DSC, when cultured up to passage 3,
exhibited a spindle-shaped morphology. DSC adopted a less
stellate form when compared to ASC (Figure 1). It should be
noted that DSC are isolated and cultured using identical
protocols as those previously described for dermal fibroblasts,
indicating that these refer to the same cell population.
To determine whether stromal cells isolated from human
dermis exhibit a similar SC marker profile to that described
for cells isolated from human adipose tissue (Zuk et al., 2002;
Oedayrajsingh-Varma et al., 2007), we analyzed surface
expression of CD31, CD34, CD45, CD54, CD90, CD105,
CD166, HLA-ABC, and HLA-DR. The analyses were per-
formed for uncultured SVF and cultured SCs derived from
adipose tissue and dermis of human skin (Figure 2; Table 1).
Both ASVF and DSVF contained a small percentage of cells
expressing the common leukocyte marker CD45 (LCA), the
cell-surface glycoprotein CD105 (endoglin) and the adhesion
molecule CD166 (ALCAM). Both ASVF and DSVF contained
large percentages of cells expressing the common endothelial
marker CD31 (PECAM-1), the common hematopoietic SC
marker CD34, the adhesion molecule CD54 (ICAM-1), the
mesenchymal marker CD90 (thy-1), HLA-ABC, and HLA-DR.
The observed CD marker profile for DSVF is similar to the
profile of ASVF, although CD34 and CD90 were significantly
lower, and both classes of HLA molecules were higher on
DSVF when compared to ASVF.
Next, cultured ASC and DSC (passage 3), derived from the
same three donors as the SVF, were characterized (Figure 2,
Table 1). Upon culturing expression of CD31, CD45 and
HLA-DR was lost on both cell types. The CD marker profile
observed for DSC is comparable to that of ASC, although
CD34 and CD166 expression were slightly decreased on DSC
when compared to ASC. In summary, the phenotype of DSC
is essentially similar to that of ASC.
Differentiation potential of ASC and DSC
The capacity of cultured (passage 3) DSC to differentiate into
lineage-specific pathways was next studied and compared to
the well-known multipotency of ASC. Similar to ASC, DSC
did show trilineage differentiation capacity toward
ASC DSC
Figure 1. ASC and DSC differ in morphology. Morphology of adipose-
derived stem cells (ASC) and dermal-derived stromal cells (DSC) of human
abdominal skin cultured at passage 3 is shown. Note the more stellate form of
ASC and the spindle shaped form of DSC. Data shown are from one individual
donor (adipose and dermis matched) and are representative of experiments
performed with three donors in duplicate; scale bar¼ 25mm.
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adipogenic, chondrogenic, and osteogenic pathways,
although to a somewhat lesser degree than ASC (Figure 3).
When culturing the cells in chondrogenic medium, chon-
drogenic pellets were observed as shown by collagen type II
staining and Alcian blue staining of proteoglycans (Figure 3a).
Also, SOX-9 gene expression was observed by reverse
transcription–PCR (ASC compared to DSC: P¼0.81; Figure
3d). Osteogenic induction of ASC and DSC resulted in
osteogenic matrix formation. Calcium phosphate mineraliza-
tion, typical for mature osteoblasts, was visualized by Von
Kossa staining (black nodules; Figure 3b). The late osteogenic
marker COL1a was observed by reverse transcription–PCR
(ASC compared to DSC: P¼ 0.27; Figure 3e). Culturing ASC
and DSC with adipogenic medium resulted in intracellular
Oil red O staining of lipid vacuoles (Figure 3c). In agreement,
PPARg was detected by quantitative RT-PCR (DSC compared
to ASC: P¼0.035; Figure 3f). Therefore, in summary,
multipotent SC populations do reside in the dermis of human
adult skin in addition to the adipose tissue.
Chemokine receptor expression on ASC and DSC
Having observed that cells residing in dermis of human skin
exhibit SC characteristics similar to that previously reported for
ASC, we next determined the CKR profiles on both ASC and DSC
(Figure 4, Table 2). First, CKR profiles of the uncultured ASVF
and DSVF were determined. Both cell populations demonstrated
a similar heterogeneous expression of CCR3, CCR4, CCR6,
CCR10, CXCR1, CXCR2, CXCR3, and CXCR4. However, a
minor but significantly lower expression of CCR10 was observed
on DSVF compared to ASVF. Neither ASVF nor DSVF showed
expression for CCR1, CCR2, CCR5, CCR7, and CCR8.
The CKR profile on cultured ASC and DSC (passage 3),
derived from the same 3 donors as the SVF, was next determined
(Figure 4, Table 2). Both cultured cell populations demonstrated
a similar homogeneous expression of CCR3, CCR4, CCR6,
CCR10, CXCR1, and CXCR2. However, a minor but significantly
lower expression of CCR3, CCR6, and CCR10 was observed on
DSC compared to ASC. Neither ASC nor DSC showed
expression for CCR1, CCR2, CCR5, CCR7, CCR8, and CXCR3.
Receptor protein expression on cultured ASC and DSC
(passage 3) was confirmed by western blot analysis using the
same antibodies as for FACS analysis. Western blot profiles
for CCR1, CCR3, CCR4, CCR6, CCR10, and CXCR1
demonstrated a single band of approximately B38 kDa,
which is in agreement with the theoretical size (B40 kDa),
calculated from the known amino-acid sequence of the
CKRs. In contrast, both Western blot profiles for CXCR2 and
CXCR4 showed two separate bands each of approximately
B38 kDa, most likely indicating two isoforms for these
receptors, which is in agreement with results from others
(Ludwig et al., 2000; Wynn et al., 2004). All receptors
detected by FACS analysis on ASC and DSC were detectable
using Western blot analysis, with the exception of CCR1,
which was only detected by Western blot analysis. CCR2,
CCR5, CCR7, CCR8, and CXCR3 were not detectable on
cultured ASC and DSC, neither by FACS analysis nor western
blot analysis. No bands were observed on the western blots
when the isotype (negative) control antibodies (IgG1 and
IgG2b) were used.
In summary, both uncultured and cultured cells, isolated
from the adipose tissue and dermis of human skin have
essentially similar CKR profiles.
Effect of chemokines on migration of ASC and DSC
An in vitro wound-healing scratch assay was used for a
functional analysis of receptor expression on the ASC and DSC
(Figure 5a). The ability of ASC and DSC to migrate upon
exposure to CK ligands, corresponding to receptors shown to be
present on the cell surfaces, was compared.
ASVF ASC DSVF
CD31/PECAM-1
CD34
CD45/LCA
CD54/ICAM-1
CD90/Thy-1
CD105/Endoglin
CD166/ALCAM
HLA-ABC
HLA-DR
DSC
DermisAdipose tissue
CD31/PECAM-1
CD34
CD45/LCA
CD54/ICAM-1
CD90/Thy-1
CD105/Endoglin
CD166/ALCAM
HLA-ABC
HLA-DR
Figure 2. The phenotype of DSC is essentially similar to that of ASC.
Phenotypic characterization of the stromal vascular fraction and stem cells
derived from adipose tissue (ASVF/ASC) or dermis (DSVF/DSC) of human skin.
Cells were stained with mAb against the indicated PE-labeled CD markers
(thick line). Each histogram plot contains a PE-labeled isotype-matched mAb
control (thin line). Data shown are from one individual donor (adipose tissue
and dermis matched) and are representative of experiments performed with
three donors in duplicate. Corresponding percentages of positive cells are
given in Table 1.
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Results were divided into three categories based on the
ability of a CK to increase cell migration (Figure 5). In agreement
with the similar CKR profile of ASC and DSC, no significant
differences were observed between migration of ASC and DSC
for all CKs tested. CKs that increased the migration of the cells
(indicated with a þ or þ þ in Table 3) all showed dose-
dependent activities, with dose-effect maxima at 250ngml1
recombinant CK (Figure 5c–e). Notably the CK ligand resulting
in the highest degree of migration above control was CCL5.
When comparing CKR expression and migration after
corresponding CK ligand exposure the following could be
observed:
(1) For CCR3, CCR4, CCR6, CCR10, CXCR2, and CXCR4
surface-protein expression was observed on ASC and DSC,
both by FACS and western blot analysis. In agreement, CK
ligands corresponding to only these receptors (namely,
CCL18 for CCR3; CCL17 and CCL22 for CCR4; CCL20 for
CCR6; CCL27 for CCR10; CXCL1 for CXCR2, CXCL12 for
CXCR4) were able to increase migration of ASC and DSC
compared to the medium control;
(2) For CXCR1 surface-protein expression was observed by
both FACS and western blot analysis. However, as its
only ligand, CXCL8 was also able to bind to CXCR2, it
cannot be concluded from these results whether CXCR1
is functional in inducing cell migration;
(3) For CCR1, protein expression was detected on ASC and
DSC only by western blot analysis, which detects both
extracellular and intracellular proteins in contrast to FACS
analysis that detects surface marker expression. Since
ligands for CCR1 (CCL4, CCL14, and CCL16) were able to
induce cell migration while other receptors (CCR2, CCR5,
and CCR8) to which they are able to bind to are absent,
we can conclude that the CCR1 receptor is functional in
inducing cell migration. It is possible that the protein for
CCR1 was present at a level below the detection limit of
our FACS analysis, or that the receptor is expressed only
intracellular and translocated to the cell surface upon
introducing the wound in the scratch assay;
(4) For CCR7 no protein expression was found. CCL19 and
CCL21, which can only bind to CCR7, do however
induce cell migration. As mRNA was detected with the
aid of a PCR array (SuperArray, Bioscience Corporation
(APHS 022A, USA) data not shown), it is possible that
the protein for CCR7 was present at a level below the
detection limit of our FACS and western blot analyses,
or that the receptor was upregulated locally at the site of
the wound in the scratch assay;
(5) CCR3 is expressed on ASC and DSC. However, only
CCL5, CCL7, CCL13, CCL15, and CCL18 stimulated
migration whereas other ligands (CCL8, CCL11, CCL24,
CCL26) did not stimulate cell migration. It is possible that
these ligands induce other cellular processes upon
receptor binding;
(6) In the wound-healing scratch assay, CK CCL5 had the
most potent effect in mobilizing both ASC and DSC into
the area of the scratch.
Figure 5a shows cells elongating, aligning, and migrating in a
directional rather than random manner into the area of the
scratch. This is suggestive of chemotaxis. However, as the
wound-healing scratch assay measures the degree of cell
motility without distinguishing between chemotaxis and
chemokinesis, we next confirmed that chemotaxis was involved
using a transwell filter assay (Figure 6). Indeed, a strong dose-
dependent chemotaxis response of ASC and DSC toward CCL5/
RANTES occurred. CCL5/RANTES has four receptors (CCR1, 3,
4, 5; Appay and Rowland-Jones, 2001; Juremalm et al., 2002)
of which three (CCR1, CCR3, and CCR4) were detected on the
protein level. Notably, the present results show that CCR5,
which plays a pivotal role in mediating CCL5-induced
migration of leukocytes, is not expressed on ASC and DSC.
Table 1. Surface marker expression in the stromal vascular fraction and cultured stem cells derived from adipose
tissue or dermis of human skin
Percentage of positive cells Percentage of positive cells Significance
CD marker ASVF ASC DSVF DSC DSVF versus ASVF DSC versus ASC
CD31/PECAM-1 39.95±8.64 0.00±0.00 47.06±5.16 0.05±0.02 NS NS
CD34 84.89±5.84 46.33±9.68 62.32±9.65 28.06±9.65 k k
CD45/LCA 2.02±2.80 0.00±0.00 9.09±2.95 0.06±0.02 NS NS
CD54/ICAM-1 74.33±4.23 76.58±1.53 77.52±7.89 79.52±5.69 NS NS
CD90/Thy-1 85.98±7.05 99.5±0.73 63.61±2.43 99.74±0.46 k NS
CD105/endoglin 14.21±8.53 96.05±3.24 15.28±9.69 92.64±6.21 NS NS
CD166/ALCAM 5.11±1.05 89.09±3.03 7.94±3.24 77.5±4.32 NS k
HLA-ABC 76.37±6.93 95.38±2.83 95.09±5.63 83.06±13.93 m NS
HLA-DR 20.94±8.33 0.00±0.00 41.07±5.96 0.00±0.00 m NS
ASC, adipose-derived stem cells; ASVF, adipose-derived stromal vascular fraction; DSC, dermal-derived stromal cells; DSVF, dermal-derived stromal
vascular fraction; NS, not significant.
Flow cytometry dot-plot data from three donors (all cell populations were donor matched) were collected and the mean number of positive cells for each CD
marker is expressed as a percentage of total cell number±standard deviation (mean±SD). Statistical significant difference between DSVF versus ASVF and
DSC (p3) versus ASC (p3) was calculated using a paired Student’s t-test, significant lower/higher expression in dermal cell populations are indicated with an
arrow pointing down/up (Po0.05).
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Figure 3. Multilineage differentiation potential of ASC and DSC. Induction of ASC and DSC toward lineage specific pathways was studied by
(immuno)histochemistry. (a) Chondrogenic differentiation—histology. Representative pellets stained for collagen with collagen type II immunostaining (scale
bar¼ 25 mm) and for proteoglycans with Alcian blue staining (scale bar¼ 50mm). After 2 weeks of culture. (b) Osteogenic differentiation—histology.
Representative image of 3 weeks osteogenic cultures stained for calcium phosphate matrix production by Von Kossa staining; scale bar¼100 mm. (c) Adipogenic
differentiation—histology. Representative images of 3 weeks adipogenic cultures stained for lipid vacuoles by Oil red O visualize histology of adipogenesis.
Data shown are from one individual donor (adipose tissue and dermis matched) and are representative of experiments performed with three donors in duplicate;
scale bar¼ 1mm. (d) Chondrogenic differentiation—relative SOX-9 (marker for early differentiation) expression normalized for means of housekeeping gene
expression. (e) Osteogenic differentiation—relative COL1a (marker for late differentiation) expression normalized for means of housekeeping gene expression. (f)
Adipogenic differentiation—relative PPARg expression normalized for means of housekeeping gene expression. Significant differences between ASC and DSC
were calculated using a paired Student’s t-test. *Po0.05. In the graphs, the mean±SEM is presented of three individual experiments performed with three
donors (adipose tissue and dermis matched) in duplicate.
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To demonstrate that the cellular activity as observed in the
wound-healing scratch assay is because of CK-mediated
migration and not proliferation, a BrdU assay was performed
using similar culture conditions as for the wound-healing
scratch assay but with subconfluent cultures. In this experi-
mental setup, none of the CKs tested affected the proliferation
rate of ASC and DSC. No difference in proliferation was
observed between control- (medium without CK) and CK-
stimulated cells whereas epidermal growth factor (EGF)
significantly increased the proliferation rate of ASC and
DSC (data not shown). To determine whether local enhanced
proliferation of cells occurred at the wound margins a Ki67
staining was performed using an identical experimental setup
as the wound-healing scratch assay. As CCL5 has the most
significant effect on cell mobilization, this CK was used for
this experiment as representative of all CKs tested. Figure 5b
shows that CCL5/RANTES does not enhance proliferation of
cells near and at the wound margins in the wound-healing
scratch assay, although addition of EGF does increase
proliferation of these cells.
DISCUSSION
Results from this study show that multipotent SCs are present
in dermis of human adult skin, which to our knowledge is
previously unreported. Moreover, it is demonstrated that SCs
residing in the dermis and the adipose tissue of human skin
have a similar SC phenotype and both are able to undergo
multilineage differentiation. Interestingly, it should be noted
that DSC and ASC are the same cell population, which have
in the past been called dermal, and adipose-derived
fibroblasts by us and others (Van den Bogaerdt et al., 2002;
Gibbs et al., 2006). This indicates that the previously named
fibroblast has clearly defined, and not yet described, SC
characteristics. Of note, ASC and DSC described in this study
should be distinguished from fibrocytes. Although fibrocytes
show some resemblance to ASC and DSC in their morphol-
ogy and in the expression of CD34, CD54, CD90, and CCR3,
they are unique in expressing CD45, linking these cells to the
hematopoietic system (Metz, 2003).
Besides showing a similarity in SC characteristics, ASC
and DSC were also found to express a similar functional CKR
profile. Higher CKR expression is observed on the SVF
isolated from adipose tissue and dermis, when compared to
cultured ASC and DSC. This is most probably because of the
heterogeneity of the cell population (for example, SCs,
endothelial cells, and infiltrating cells such as macrophages).
This study describes the repertoire of CKR expressed on ASC
and DSC at the protein level coupled to an in vitro functional
migration assay, which to our knowledge is previously
unreported. Low, but distinct levels of CCR1, CCR3, CCR4,
ASVF ASC
Adipose tissuea
b
CCR2
CCR3
CCR4
CCR6
CCR10
CXCR1
CXCR2
CXCR3
CXCR4CXCR4
m
49 kDa
38 kDa
28 kDa
49 kDa
38 kDa
28 kDa
CCR1
CXCR1 CXCR2 CXCR4 lgG1 lgG2b
CCR3 CCR4 CCR6 CCR10
mA AD D m mmA AAD D D
m mA AD D m mmA AAD D D
CXCR3
CXCR2
CXCR1
CCR10
CCR6
CCR4
CCR3
CCR2
DSVF DSC
Dermis
Figure 4. Chemokine receptor expression on ASC and DSC.
(a) Characterization of chemokine receptor expression on the stromal vascular
fraction and stem cells derived from adipose tissue (ASVF/ASC) or dermis
(DSVF/DSC) of human skin using flow cytometry. Cells were stained with
mAb against the indicated PE-labeled chemokine receptors (thick line). Each
histogram plot contains a PE-labeled isotype-matched mAb control (thin line).
Corresponding percentages of positive cells are given in Table 2. (b) Western
blot analysis of intracellular and surface-expressed chemokine receptors on
cultured adipose stem cells (A) and dermal stem cells (D) at passage 3
identified using a size marker (m). All data shown are from one individual
donor (adipose tissue and dermis matched) and are representative of
experiments performed with three donors in duplicate.
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CCR6, CCR10, CXCR1, CXCR2, and CXCR4 were found on
cultured ASC and DSC. This is in agreement with the levels of
CKR expression described for cultured bone marrow-derived
SCs (Wynn et al., 2004; Honczarenko et al., 2006; Ponte
et al., 2007; Ringe et al., 2007). CKR expression is required to
allow SCs to be directly responsive to CK gradients created by
wounded tissue.
In accordance to expressing CKR, CKs efficiently induced
migration responses of ASC and DSC. In a functional wound-
healing assay, it was shown that exposure of ASC and DSC to
CKs stimulated an equal migratory effect in both cell types.
We showed that several CXC- and CC-CKs, with CCL5/
RANTES being clearly the most potent CK, could induce
migration of ASC and DSC in an in vitro wound-healing
assay. The scratch wound-healing assay was chosen for our
studies to complement CKR profile analysis as this enables
high throughput analysis in a dose-dependent manner of a
large panel of CKs. One limitation of this assay is that it does
not distinguish chemotaxis from chemokinesis. On the one
hand, the equal distribution of the CK throughout the medium
may result in chemokinesis. On the other hand, the
introduction of the scratch introduces the possibility that a
CK gradient may exist with respect to CK bioavailability
being highest on cell surfaces exposed to the scratch and
lowest on cell surfaces protected by the confluent layer of
neighboring cells. This may result in chemotaxis into the area
of the scratch. This hypothesis is supported by the observation
that cell elongation occurs in a directional manner into the
area of the scratch rather than in random directions. The fact
that indeed chemotaxis rather than chemokinesis is respon-
sible for cell mobility was confirmed by studying CCL5/
RANTES in the chemotaxis transwell filter assay. In addition,
assuming that bioavailability is highest on cell surfaces
exposed to the scratch for all CKs tested, the significant
effect of CCL5/RANTES compared to other CKs may be
explained by the ability of this CK to bind to multiple
receptors of which three were shown to be present on ASC
and DSC (CCR1, CCR3, and CCR4). Notably, the experi-
mental setup of our scratch assay was selected so that CKs
tested had no effect on SC proliferation and therefore our
results are entirely because of the effect of CKs on migration
and not a combined effect of proliferation and migration.
However, mitogenic effects of CXCL1, CXCL8, and CCL5 on
keratinocytes and fibroblasts have been reported (Steude
et al., 2002; Devalaraja et al., 2000). Most likely, these
different results may relate to differences in experimental
design in which we investigated the influence of CKs on ASC
and DSC under serum-free conditions thus avoiding eventual
synergism with serum components. The ability of CCL5/
RANTES to stimulate migration of ASC and DSC more than
other agonistic CKs can be best explained by the ability of
CCL5/RANTES to bind to and activate several CKR present on
ASC and DSC (CCR1, CCR3, CCR4). In addition, CCL5/
RANTES also activates a CKR-independent pathway. Induc-
tion of this pathway appears to be mediated by protein
tyrosine kinases and induces hyperphosphorylation and
generalized cell activation, triggering a variety of biologic
effects such as proliferation, cytokine release, and apoptosis
(Appay and Rowland-Jones, 2001). The role of this pathway
in migration is still unknown.
Table 2. Chemokine receptors in the stromal vascular fraction and cultured stem cells derived from adipose tissue
or dermis of human skin
Percentage of positive cells Percentage of positive cells Significance
Chemokine receptor ASVF ASC DSVF DSC DSVF versus ASVF DSC versus ASC
CCR1 0.66±058 0.09±0.05 1.01±0.89 0.06±0.05 NS NS
CCR2 0.33±0.13 0.33±0.21 6.39±3.15 0.26±0.15 NS NS
CCR3 11.14±1.09 5.88±0.28 12.04±2.66 4.78±0.50 NS k
CCR4 9.98±1.55 4.17±1.25 9.17±3.33 4.69±0.29 NS NS
CCR5 0.35±0.13 0.00±0.02 0.53±0.81 0.25±0.39 NS NS
CCR6 7.62±1.99 7.03±0.78 7.48±2.4 5.15±0.89 NS k
CCR7 0.09±0.16 0.05±0.08 0.27±0.13 0.01±0.03 NS NS
CCR8 0.99±0.42 0.08±0.14 1.02±0.57 0.06±0.02 NS NS
CCR10 14.67±1.09 5.15±0.25 11.57±1.32 4.48±0.05 k k
CXCR1 10.01±2.37 5.18±0.72 7.11±0.64 4.28±0.87 NS NS
CXCR2 11.28±3.16 5.45±1.02 8.37±0.56 5.49±0.59 NS NS
CXCR3 14.76±6.96 2.33±0.99 7.35±0.53 1.38±0.45 NS NS
CXCR4 1.66±0.9 1.21±0.23 2.57±1.2 1.31±0.30 NS NS
ASC, adipose-derived stem cells; ASVF, adipose-derived stromal vascular fraction; DSC, dermal-derived stromal cells; DSVF, dermal-derived stromal
vascular fraction; NS, not significant.
Flow cytometry dot-plot data from three donors (all cell populations were donor matched) were collected and the mean number of positive cells for each
chemokine receptor is expressed as a percentage of total cell number±standard deviation (mean±SD). Statistical significant difference between DSVF
versus ASVF and DSC (p3) versus ASC (p3) was calculated using a paired Student’s t-test, significant lower expression in dermal cell populations are
indicated with an arrow pointing down (Po0.05).
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Figure 5. Wound-healing scratch assay shows CCL5/RANTES to be most potent stimulator of SC migration. (a) A representative example of the wound-healing
scratch assay. Cells migrating to cover the cell-free area when cultured in medium alone and in medium supplemented with CCL5/RANTES are shown at days 2
and 4; scale bar¼100 mm. (b) Ki67 staining of cells in the neighborhood of the wound after supplementation of culture medium with EGF or CCL5/RANTES.
Ki67 stains proliferating cells (black nuclei); scale bar¼ 100mm. (c–e) Three groups of chemokines could be distinguished based upon their differential effect on
cell migration after 2 and 4 days exposure (see also Table 3). A representative dose–response graph for one CK from each group for both ASC and DSC at day 4 is
shown (left); a list of all chemokines within the same category is shown (right). Quantifying migration at 2 days gave similar results as the quantification of
migration at 4 days. Group (c): No effect on migration. (Table 3; indicated with ). Group (d): Migration in presence of chemokine4control, Dpmaxima 1.5-
fold (Table 3; indicated with þ ). Group (e): Migration in presence of chemokine 44control, DXmaxima twofold (Table 3; indicated with þ þ ). Statistical
significant differences between cultured cells (p3) exposed to chemokine and cells cultured in absence of CK (dotted line at 100%) were calculated using a
paired Student’s t-test. *Po0.05, **Po0.001 relative to control. All chemokines were tested with the same set of donors at the same passage. In the graph, the
dots represent the values of three individual experiments performed with three donors (adipose tissue and dermis matched) in duplicate.
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Beside CCL5 being the most potent stimulator of migration,
other CKs also had a clear dose-dependent significant effect
on migration. These results indicate that ASC and DSC can
home, in a similar manner to leukocytes, to the wound bed
via a CK gradient. This has been previously suggested for
bone marrow SCs, in which CKs and their receptors are
reported to be involved in cell migration into, for example,
the brain and the epidermis (Ji et al., 2004; Inokuma et al.,
2006). Gillitzer and Goebeler showed that skin injury is
associated with a differential and sequential expression of
CKs (Groa/CXCL1, IL8/CXCL8, SDFa/CXCL12, MIP1a/CCL3,
and RANTES/CCL5) in the wound bed (Gillitzer and
Goebeler, 2001). Their findings correlate with our results in
which we show that these five CKs increase migration of ASC
and DSC. Expression of CCL5 during early wound repair has
been shown in murine wound repair (Frank et al., 2000).
Furthermore, increased CCL5 production by human endothe-
lial cells occurs after exposure to the proinflammatory
cytokines IFN-g and tumor necrosis factor-a, which are
secreted upon skin damage (Marfaing-Koka et al., 1995). In
line with our results on ASC and DSC, CCL5 has been
reported to stimulate directional migration of bone marrow-
derived SCs (Honczarenko et al., 2006; Ponte et al., 2007).
Notably CCL19 and CCL21 (ligands for CCR7) did induce
ASC and DSC migration, whereas CCR7 could only be
detected on mRNA level (data not shown). For this receptor, it
might be postulated that it is upregulated upon introducing
the wound in the scratch assay. This would be in agreement
with CKR expression on bone marrow-derived SCs to be
upregulated by cytokines such as tumor necrosis factor-a and
IFN-g (Croitoru-Lamoury et al., 2007). This upregulation
suggests that proinflammatory signals, released upon tissue
damage, increase CKR expression on SCs, thereby further
stimulating migration of SCs toward CKs.
Interestingly, some CKs (CCL8, 11, 24, and 26) did not
induce cell migration, whereas their corresponding receptors
Table 3. Chemokine receptor expression on ASC and
DSC and the effect of corresponding chemokine
ligands on migration
Protein expression Migratory effect of
Chemokine
receptor FACS Western blot
Chemokine
ligand ASC DSC
CCR1 No Yes CCL3 + +
CCL4  
CCL5 ++ ++
CCL7 + +
CCL8  
CCL13 + +
CCL14  
CCL15 + +
CCL16  
CCR3 Yes Yes CCL5 ++ ++
CCL7 + +
CCL8  
CCL11  
CCL13 + +
CCL15 + +
CCL18 + +
CCL24  
CCL26  
CCR4 Yes Yes CCL3 + +
CCL5 ++ ++
CCL17 + +
CCL22 + +
CCR6 Yes Yes CCL20 + +
CCR7 No No CCL19 + +
CCL21 + +
CCR10 Yes Yes CCL27 + +
CXCR1 Yes Yes CXCL8 + +
CXCR2 Yes Yes CXCL1 + +
CXCL8 + +
CXCR3 No No CXCL9 ND ND
CXCL10 ND ND
CXCL11 ND ND
CXCR4 No Yes CXCL12 + +
ASC, adipose-derived stem cells; control, culture medium without
chemokine ligand; DSC, dermal-derived stromal cells; ND, not done.
Chemokine receptor expression was determined by flow cytometry for
protein expression (Figure 4). Absence of a chemokine receptor at protein
level is indicated with No, presence of the receptor with Yes. For each
chemokine receptor its corresponding agonistic chemokine ligands are
shown in combination with the effect they had on the migration of ASC
and DSC in a scratch assay. No migration is indicated with a – (migration
in presence of chemokine=control, D=0); a moderate effect is indicated
with a + (migration in presence of chemokine 4control, Dp1.5-fold), a
large effect is indicated with a ++ (migration in presence of chemokine
44control, DXtwofold).
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Figure 6. Transwell assay shows CCL5/RANTES to be chemoattractant for
ASC and DSC. Cultured ASC (white bars) and DSC (black bars) at passage 3
were incorporated into a chemotaxis transwell assay in the presence of CCL5/
RANTES supplemented in the lower well. Placing an equal concentration of
CCL5/RANTES (250 ngml1) in upper and lower well blocks the migratory
response indicating chemotaxis rather than chemokinesis. Data are presented
as the mean (±SEM) number of cells migrating to the underside of the
transwell filter. **Po0.001 relative to control. The experiments are performed
with three donors (adipose and dermis matched) in duplicate.
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were found to be expressed on protein level. This suggests a
function other than migration for these CK ligand/receptors
pairs, in line with findings elsewhere. CCL11, for example,
has been reported to increase MMP2 activity of lung
fibroblasts (Puxeddu et al., 2006). Most MMPs are known
to be secreted in vivo upon skin damage and are therefore
most probably secreted in our in vitro scratch wound assay.
For gingival fibroblasts, it has been demonstrated that MMP1
and MMP3 expression is stimulated by cytokines such as
tumor necrosis factor-a and IFN-g, suggesting that, upon
tissue damage, fibroblasts increase MMP1 and MMP3
production (Domeij et al., 2002). In turn, McQuibban et al.
reported that CKs such as CCL8 are susceptible to cleavage
by MMP1 and MMP3. These cleaved CKs may then act as
antagonist (McQuibban et al., 2002). Cleavage of CCL8, by
MMP1 and MMP3 could be a possible explanation for the
nonmigratory effect of CCL8 in our in vitro wound-healing
assay. CKs not inducing ASC and DSC migration could also
be inhibitors of cell migration, as has been reported for
CXCL10, which is an inhibitor of keratinocyte migration
(Shiraha et al., 1999). Thus CCL8, CCL11, CCL24, and CCL26
may mediate multiple effects other than affecting cell motility.
In contrast to the similarities observed in the SC phenotype,
CKR profile and CK-mediated migration; ASC and DSC did
differ in their morphology and their degree of multilineage
differentiation. To be noted is that both cell types were donor
matched and were isolated and cultured using identical
protocols. The difference in morphology between ASC and
DSC has previously been reported by Van den Bogaerdt et al.
who showed that adipose-derived mesenchymal cells (ASCs)
had a higher a-smooth muscle expression and were more
contractile than DSC (Van den Bogaerdt et al., 2002). Here,
we show that even though DSC do have trilineage differentia-
tion potential, it is to a slightly lesser degree than that
observed for ASC. One explanation for this may be that here
we show that DSC contain a smaller population of CD34þ
cells than ASC and it has been suggested by others that
CD34þ cells from SVF of adipose tissue are the precursors of
the multipotent cells in culture (Miranville et al., 2004;
Boquest et al., 2005). Therefore, even though ASC and DSC
do exhibit many similar SC and migratory characteristics they
are clearly two different cell populations.
The homing of autologous SCs into difficult to heal
wounds improves wound healing (Falanga et al., 2007;
Prichard et al., 2007). Our results indicate that beside the
adipose tissue of adult human skin, the dermis is also a source
of SCs, which to our knowledge is previously unreported. The
presence of SCs in both the dermis and adipose tissue of
human adult skin underlines the intrinsic repair capacity of
human skin, which if correctly guided may lead to optimal
tissue repair and regeneration. SCs residing in the adipose
tissue and dermis of human skin are the most likely
candidates to be directly involved in healing of deep skin
wounds as adipose tissue is generally exposed in the wound
bed and dermal tissue is exposed at the wound bed margins.
Establishing optimal CK gradients within the wound bed, for
instance with the aid of recombinant CKs, may form a basis
for SC therapies in the future for healing a broad range of
difficult to heal wounds ranging from deep burns, where the
quality of the scar is of major importance to chronic ulcers
where obtaining wound closure is of major importance.
MATERIALS AND METHODS
Isolation and culturing of mesenchymal cells from human skin
Human adult skin was obtained from healthy donors (with written
informed consent) undergoing abdominal dermolipectomy and was
used directly after surgery. The VU University medical center
approved the experiments described in this paper. The study was
conducted according to Declaration of Helsinki Principles.
Adipose stromal vascular fraction (ASVF)/ASC: Adipose tissue
was carefully dissected out from skin and large vessels. The fat was
washed with phosphate-buffered saline (PBS; B. Braun, Melsungen,
Germany), cut into small pieces, and incubated in collagenase type
II (Gibco, Invitrogen, Paisley, UK)/dispase II (Roche Diagnostics,
Mannheim, Germany) in Hanks-buffered salt solution (Gibco,
Invitrogen) at 37 1C for 2 hours. Enzymatic activity was then
neutralized by adding PBS supplemented with 0.1% BSA (Sigma-
Aldrich, Steinheim, Germany) to the tissue-enzyme solution. The
adipose-derived cells were separated from tissue debris in a filter
chamber (NPI, Emmer-Compascuum, the Netherlands) after which
the cell suspension was centrifuged (400 g, 6minutes). The cell
pellet was then resuspended in DMEM (ICN Biomedicals, Verviers,
Belgium), containing 1% ultroserG (Pall, Cergy-Saint-Christopher,
France) and 1% penicillin–streptomycin (P/S; Gibco, Invitrogen) and
passed through a 40-mm-cell strainer (Becton Dickinson Falcon,
Erembodegem, Belgium). Next, nucleated cells were separated by a
Ficoll-paque PLUS (GE Healthcare Biosciences, Uppsala, Sweden)
density filtration step and viability of the cells was assessed using
Trypan blue. A total of 5 106 of the freshly isolated ASVF cells were
resuspended in 1ml DMEM, 1% P/S, 1% ultroserG, and 10% DMSO
(Sigma-Aldrich) and stored in the vapor phase of liquid nitrogen.
Single cell suspensions of ASVF were seeded at 1 105 cells/cm2 in
DMEM containing 1% P/S and 1% ultroserG and maintained in a 5%
CO2 incubator at 37 1C in a humidified atmosphere. When these
cells are cultured they are called ASC.
Dermal stromal vascular fraction (DSVF)/DSC: Care was taken
that all adipose tissue was removed before separating epidermis from
dermis. Epidermal sheets and dermis were separated from human
adult skin by incubation in dispase II overnight at 4 1C. The dermis
was treated as described above for adipose tissue. A total of 5 106
of the freshly isolated DSVF cells were resuspended in 1ml DMEM,
1% P/S, 1% ultroserG, and 10% DMSO and stored in the vapor
phase of liquid nitrogen. Single cell suspensions of DSVF were
seeded at 1 105 cells/cm2 in DMEM containing 1% P/S and 1%
ultroserG and maintained in a 5% CO2 incubator at 37 1C in a
humidified atmosphere. Upon culturing these cells are called DSC.
Cells derived from the dermis and adipose tissue of the skin were
cultured identically and medium was changed twice a week.
Cultures were passaged when 90% confluent using 0.5mM EDTA/
0.05% trypsin (Gibco, Invitrogen).
Flow cytometric analysis
Freshly isolated and cultured (passage 3) cells from the adipose
tissue and dermis of human skin were examined for cell-surface
marker expression using flow cytometry. Cells were incubated with
antibodies for 30minutes, washed in PBS supplemented with 0.1%
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BSA, and 0.1% sodium azide and resuspended in the same buffer for
FACS analysis. Cells were measured on a FACScan and analyzed
with Cell Quest software (Becton Dickinson Immunocytometry
Systems, Mountain View, CA). PE-labeled antibodies and corre-
sponding isotypes used are from BD Pharming, San Diego, CA,
generated in mouse and reactive with human unless stated
otherwise. CD31 (WM59, IgG1); CD34 (581, IgG1); CD54 (HA58,
IgG1); CD90 (5E10, IgG1); CD105 (SN6, IgG1, Caltag); CD166
(3A6, IgG1); HLA-DR (L243, IgG2a); HLA-ABC (G46-2.6, IgG1);
CCR1 (53504, IgG2b); CCR2 (48607, IgG2b); CCR3 (5E8, IgG2b);
CCR4 (1G1, IgG1); CCR5 (2D7, IgG2a); CCR6 (11A9, IgG1); rat anti-
human CCR7 (3D12, IgG2a); rat anti-human CCR8 (191704, IgG2b,
R&D systems, Oxon, UK); rat anti-human CCR10 (314305, IgG2a,
R&D systems); CXCR1 (5A12, IgG1); CXCR2 (CDw128b, IgG2b);
CXCR3 (1C6/cxcr3, IgG1); CXCR4 (12G5, IgG2a, R&D systems).
Protein preparation and western blot analysis
ASC and DSC at passage 3 were rinsed with PBS and lysed in ice-
cold NET (20mM Tris, 100mM NaCl, 1mM EDTA) with 0.5% Triton
X-100 and one tablet per 50ml lysis buffer of Complete Protease and
phosphatase inhibitors (Roche Diagnostics). Lysates were centri-
fuged and the protein content in the supernatant was quantified
using protein assay as described by the manufacturer (Bio-Rad
Laboratories, Hercules, CA). Thereafter, 1 of 4 final volume of four
times NuPAGE sample buffer and 1 of 10 volume reducing agent
(stabilized DTT) were added to protein samples. Next, protein
samples were heated for 5minutes at 95 1C before loading (5–10mg)
and size separation on precast 1mm thick Bis-Tris (10%) NuPAGE
gels with MES as running buffer according to manufacturer’s
instructions (Invitrogen). After size separation, the proteins were
transferred to nitrocellulose membranes with the iBlot Dry-blotting
System (Invitrogen) according to program number two of iblot device
97minutes of transfer).
For Western blot analysis, the blots were incubated in blocking
buffer (DPBS (Gibco, Invitrogen), containing 1% BSA (Roche
Diagnostics) and 0.1% Tween (Merck, Whitehouse Station, NJ)
for at least 30minutes. Blots were then incubated with primary
antibodies at room temperature for 1 hour followed by o/n
incubation at 4 1C. All primary antibodies and isotype (negative)
controls used (1:250 dilution) are listed in the FACS analysis section.
Only for CCR10, another primary antibody was used (1:250 dilution;
goat anti-human CKR10, N20, IgG2a, Santa Cruz Biotechnology,
California). Membranes were washed three times for 5minutes
in blocking buffer. Blots were incubated with rabbit anti-mouse AP-
conjugated antibody (Dako, Glostrup, Denmark; 1:2,000 dilution) or
rabbit anti-goat AP conjugated antibody (Santa Cruz Biotechnology;
1:2,000 dilution) for 1 hour at room temperature. Membranes were
washed in Tris-buffered saline (50mM Tris, 150mM NaCl, pH 7.5),
followed by AP buffer (0.2 M Tris, 0.1 M MgCl2, 0.2 M NaCl2, 1mM
levamisole, pH 9.7) for 5minutes. Specific protein detection was
achieved using chromogen NBT/BCIP substrate of AP (1:100
dilution; Roche Diagnostics) as described by manufacturer’s
instructions. Blots were imaged using HP scanjet 5590.
Differentiation potential ASC and DSC
Adipogenic, chondrogenic, and osteogenic differentiation capacities
of cultured (passage 3) ASC and DSC (n¼ 3) were studied within the
same donor.
Adipogenesis was induced by culturing ASC and DSC for 3 weeks in
monolayer at a concentration of 2.0 105 cells/well in adipogenic
medium (DMEM, supplemented with 2% ultroserG, 100Uml1
penicillin, 100mgml1 streptomycin, and 2mM L-glutamine (Gibco,
Invitrogen), 10mM insulin (Sigma-Aldrich, Zwijndrecht, the Netherlands),
0.5mM 3-isobutyl-1-methylxanthine (IBMX, Sigma-Aldrich), 1mM dexa-
methasone (Sigma-Aldrich), and 200mM indomethacin (Merck) for 3
weeks.
Chondrogenic differentiation was induced for 2 weeks using a
micromass culture method, as previously described (Oedayrajsingh-
Varma et al., 2006). Chondrogenic medium (DMEM, containing
ITSþ premix (final concentration in medium when diluted 1:100
insulin, 6.25 mgml1, transferrin, 6.25 mgml1, selenous acid,
6.25 ngml1, BSA, 1.25mgml1, linoleic acid, 5.35 mgml1; Becton
Dickinson), 10 ng nl1 transforming growth factor-b1 (Biovision, ITK-
diagnostics, Mountain View, CA), 0.2% ultroserG, 25 mM
ascorbate-2-phosphate (Sigma, St Louis, MO, USA), 100Uml1
penicillin, 100 mgml1 streptomycin, and 2mM L-glutamine was
overlaid gently. Cells were maintained in a 5% CO2/1% oxygen
custom-designed hypoxia workstation (T.C.P.S. Rotselaar, Belgium)
at 37 1C in a humidified atmosphere.
For osteogenic differentiation, ASC and DSC were seeded at
5,000 cells/cm2 and cultured for 3 weeks in monolayers in
osteogenic medium, consisting of normal culture medium supple-
mented with 100 nM dexamethasone, 10mM b-glycerol phosphate,
50 mgml1 ascorbate-2-phosphate, and 100ngml1 bone morpho-
genetic protein 2 (Peprotech EC Ltd, London, UK).
(Immuno)histochemistry
(Immuno)histochemistry was performed as described previously
(Oedayrajsingh-Varma et al., 2007). Cell nodules formed under
chondrogenic culture conditions were fixed in 4% paraformalde-
hyde and paraffin sections were stained. Sections were stained with
Alcian blue (Sigma-Aldrich) at acidic pH for detection of proteogly-
cans. For the detection of collagen type II, sections were incubated
with mouse monoclonal antibody II-II6B3 (1:50; Developmental
Studies Hybridoma Bank, IA) against human collagen type II in PBS
containing 1% BSA.
Cells that were induced into the osteogenic lineage for 21 days
were examined by Von Kossa staining to demonstrate the formation
of a calcified matrix that is typical for mature osteoblasts. The
protocol used was described previously (Oedayrajsingh-Varma
et al., 2007). Calcified extracellular matrix was visualized as black
spots.
Adipogenesis was confirmed by staining the cells with Oil
red O after 21 days to visualize lipid vacuoles formed
after adipogenic induction as described previously (Zuk et al.,
2002).
Real-time PCR
RNA isolation and reverse transcription were performed as
previously described (Oedayrajsingh-Varma et al., 2007). Real-time
PCR reactions were performed using the SYBRGreen reaction kit
according to the manufacturer’s instructions (Roche Diagnostics) in a
LightCycler 480 (Roche Diagnostics). Relative housekeeping gene
expressions (18S, HPRT, and YWHAZ), and relative target gene
expressions (SOX-9 for early chondrogenic differentiation at 4 days;
COL1a for late osteogenic differentiation at 2 weeks; PPARg for
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adipogenic differentiation at 2 weeks) were determined. Primers
(Invitrogen) used for real-time PCR were 18S forward: 50 GTAACCC
GTTGAACCCCATT-30, reverse: 50 CCATCCAATCGGTAGTAGCG-30;
HPRT, YWHAZ; COL1a1, forward: 50-AAGCCGAATTCCTGGTC
T-30, reverse: 50-TCCAACGAGATCGAGATCC-30; PPARg; SOX-9
and were designed using Clone Manager Suite software program
version 6 (Scientific & Educational Software, Cary, NC, USA).
For real-time PCR, the values of relative target gene expression were
normalized for means of relative 18S, HPRT, and YWHAZ house-
keeping gene expression.
Wound-healing scratch assay for quantifying cell migration
Wound-healing scratch assay was performed essentially as
described by Entschladen et al. (2005). Confluent cell monolayers
in a 48-well plate were incubated with serum-free medium
(DMEM, 1% P/S, 0.1% BSA (Sigma-Aldrich) for 4 days. After 4 days,
a scratch was drawn with a plastic disposable pipette tip. Cultures
were washed with PBS to remove detached cells and then exposed
to different concentrations of CKs (62.5, 125, 250, and 500ng CK
per ml DMEM, 1% P/S, 0.1% BSA; R&D Systems). Media was
changed after 2 days of exposure. The wound area was photo-
graphed (when the monolayer was damaged (t¼ 0) and at 2 days
(t¼ 2) and 4 days (t¼ 4) after scratching), using phase contrast
microscopy coupled to a digital camera (Coolpix 5400, Nikon
Corporation, Japan). In the photograph of t¼ 0, the wound is marked
by black lines using Microsoft Digital Image Pro 7.0. This defined
wound area of t¼ 0 is copied to photographs taken at t¼ 2 and t¼ 4
days, for each individual condition. Cells that have migrated into the
defined wound area at t¼ 2 and t¼ 4 days are counted. The number
of cells, which migrated into the wound area of the control (without
CK) after 2 and 4 days, is set at 100%. Cell migration in CK-
supplemented medium was compared to control medium and given
as a percentage relative to control (100%). All experiments were
performed in duplicate using three different donors. Each donor
(cultured to p3) was used to test the complete panel of CKs in ASC
and DSC.
Assessment of cell proliferation
BrdU. Before the BrdU assay, cells were cultured for 4 days in
Serum free medium. Subconfluent cell monolayers (75%),
in a 96-well plate, were wounded as described above for the
wound-healing scratch assay. Cultures were exposed to different
concentrations of CKs (0, 7.5, 15, 30, 62.5, 125, 250, and 500 ng CK
per ml medium) for 2 and 4 days. Incorporation of BrdU (10 ml
100mM BrdU per well) during the final 16 hours of incubation was
assessed in triplicate following the standard protocol described by
the manufacturer’s (Amersham, Biosciences, UK). All experiments
were performed in at least three different donors in duplicate. EGF
(10 ng ml1) was used as positive control.
Ki67 immunostaining. ASC and DSC were seeded onto sterile
glass chamber slides (Nalge Nunc International, Rochester, NY,
USA). Cells were grown to confluence and incubated with serum-
free medium (DMEM, 1% P/S, 0.1% BSA; Sigma-Aldrich) for 4 days.
After 4 days a scratch was introduced and cells were exposed to
CCL5/RANTES (250 ngml1) as previously described for the wound-
healing scratch assay. EGF (10 ngml1) was used as positive control.
After 2 and 4 days, slides were fixed with ice-cold ethanol for
10minutes, incubated in PBS-containing goat serum (Dako; 1:50) for
15minutes, before incubation with Ki67 (clone MIB-1, Dako; 1:50)
for 60minutes. Thereafter, slides were incubated with goat anti-
mouse biotin-conjugated secondary antibody (Dako; 1:400) for
30minutes. Specific protein detection was achieved by incubation in
streptavidine-HRP (Dako; 1:500) for 30minutes and lightly counter-
staining with hematoxylin.
Chemotaxis assay
Chemotactic responses of ASC and DSC to CCL5/Rantes were
assessed by the Boyden well chamber technique using a
24-transwell system and 8mm poresize (Costar, Corning, NY). Before
chemotaxis cells were incubated for 4 days in DMEM, 1% P/S, 0.1%
BSA. Cell suspension (200 ml; 2.5 105/ml in DMEM, 1% P/S, 0.1%
BSA) was loaded into the upper well of the chamber and allowed to
attach overnight. After overnight attachment of the cells CCL5/
RANTES (0–500 ngml1) diluted in DMEM was placed in the lower
chamber. Additionally to discriminate between chemotaxis and
chemokinesis, 250 ngml1 CCL5/RANTES was placed in both upper
and lower well. Chambers were incubated for 24 hours, after which
the cells that did not migrate were wiped from the upper surface of
the transwell with a cotton swab. Transwells were then washed in
PBS, fixed using 4% formaldehyde (Klinipath, Duiven, the Nether-
lands), washed again in PBS, and stained with 10 mM propidium
iodide (Invitrogen). The number of cells on the lower surface of the
filter was determined by counting the number of nuclei in  40
magnification under a computer-assisted fluorescence microscope
(Nikon, Du¨sseldorf, Germany). Three independent experiments were
performed where duplicate wells were prepared in each experiment
for each condition.
Experimental setup
All experiments were carried out using freshly isolated ASVF
and DSVF, or ASC and DSC at passage 3, cultured for the same
number of days and from the same donor. Three different donors
were used and experiments with each donor were performed
in duplicate.
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